Monkeypox Disease Diagnostics Market Overview
Monkeypox is caused by Monkeypox virus, a member of the Orthopoxvirus genus in the family Poxviridae. Monkeypox is a viral zoonosis i.e a virus transmitted to humans from animals. The symptoms are similar to those seen in the past in smallpox patients. With the eradication of smallpox in 1980 & subsequent cessation of smallpox vaccination, Monkeypox has emerged as the most important Orthopoxvirus for public health. Rope squirrels, tree squirrels, Gambian pouched rats, dormice, non-human primates & other species are the natural hosts of Monkeypox virus. Monkeypox is a self-limited disease with the symptoms lasting from 2 days to weeks, severe cases can occur. Monkeypox virus is transmitted from one person to another by close contact with lesions, body fluids, respiratory droplets & contaminated materials such as bleeding. Monkeypox typically presents clinically with fever, rash & swollen lymph nodes & may lead to a range of medical complications like bronchopneumonia, sepsis, encephalitis, & infection of the cornea with ensuing loss of vision.
Human Monkeypox was first identified in humans in 1970 in the Democratic Republic of the Congo in a 9-month old boy in a region where smallpox had been reported from rural, rainforest regions of the Congo Basin, particularly in the Demcratic Republic of the Congo & human cases have increasingly been reported from across central & west Africa. Therapeutics, vaccination are in demand for the diagnosis of monkeypox virus.
Monkeypox Disease Diagnostics Market Dynamics
Rise prevalence of monkeypox virus among the human population
Sudden prevalence of Monkeypox virus has led to increase in growth of Monkeypox Disease Diagnostic market. Confirmation of Monkeypox depends the type & quality of the specimen & the type of laboratory tests. Rise in confirmatory tests by PCR, available home kits like Rapid Antigen Test is one of the leading factors for the global Monkeypox disease diagnostic market growth. Moreover, increasing urban population is one of the driving factors for the Monkeypox disease diagnostics market. In May 2022, the Salt Lake Country Health Department reported two real-time Polymerase chain reaction (PCR) - confirmed travel-associated cases of Monkeypox Utah Department of Health and Health Services (UDHHS). Further, 14,115 total confirmed Monkeypox cases in U.S. 2022. Thus, sudden increase in the monkeypox disease and rising population is expected to exhibit growth in Global Monkeypox Disease Diagnostics Market. Moreover, travelling restrictions across country to prevent outbreak of Monkeypox virus has led to increase in PCR confirmatory tests. PCR tests with its incredible sensitivity, specificity, and speed amplification has led to increase in growth in Monkeypox disease diagnostic market. PCR has challenged the other diagnostic test for confirmation of disease. However, PCR has becoming the dominating confirmatory test due to its accuracy on the other test kits in the market.
Technological advancement
In July 2022, Indian Council of Medical Research, New Delhi invites Eols (expressions of interest) for Collaboration for development of In-Vitro Diagnostic (IVD) Kits and Vaccine candidate against Monkeypox Virus (MPXV). Further, U.S. based Grand River Aseptic Manufacturing will fill & finish 2.5 million of 5.5 million vials of JYNNEOS Monkeypox vaccine ordered by the Department of Health and Human Services to make available to individuals at high risk for the virus, which in all supports the growth of the target market.
Further, the NGOs and Governments are taking initiatives to flexible policies for key players, For instance, NIST (National Institiute of Standards and Technology) is making the new material freely available to testing laboratories and diagnostic test manufacturers world-wide. The material contains genes fragments from the virus that causes the disease but is noninfectious and safe to handle, freely available for use by test manufacturers and testing laboratories.
Restrains:
Lack of awareness
Responding to a Monkeypox outbreak will require strong collaboration of the government & frontline healthcare workers. People living in rural areas are at risk of outbreak of Monkeypox disease. Due to lack of education, lack of knowledge there is no prevention or medical care taken by the people. According to the report March, 23, 2020, (PubMed Central), Knowledge of human Monkeypox viral infection among general practitioners: a cross sectional study in Indonesia, the data indicates that the level of knowledge of Monkeypox among GPs in Indonesia is very low. Less than 10% were able to answer 80% of 21 questions correctly. Using an 80% cutoff, none of the explanatory variable were associated with the level of knowledge indicating a uniformly low level of knowledge on Monkeypox across the studied characteristics. Systematic strategies for enhancing the capacity of GPs to gain knowledge about the human Monkeypox will be important to prepare for any response to a future outbreak.
However, increase in population and low awareness in rural areas & lack of knowledge about the outbreak of disease is expected to restrain the growth of the target market.
Monkeypox Disease Diagnostics Market Segmentation
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
The Global Monkeypox Disease Diagnostics Market is segmented based on type, application, and region. On the basis of type, the Global Monkeypox Disease Diagnostics Market is segmented into PCR (Polymerase Chain Reaction), Biopsy, Antigen Detection Method, Rapid Test Kits and Others.
For instance, GeneXpert MPX/OPX Assay, Trivitron Healthcare Monkeypox Antigen Rapid Test Kit and Monkeypox IgM/IgG Antibody Rapid Test Kit, VivaDiag™ Monkeypox Virus IgM/IgG Test Kit (FIA), Elabscience Human Monkeypox IgG/IgM Lateral Flow Assay Kit, Aurora Biomed Monkeypox Virus Real Time PCR KIT(CE CERTIFIED), JOYSBIO (Tianjin) Biotechnology Co., Ltd Monkeypox Antigen Rapid Test Kit & Monkeypox IgM/IgG Antibody Rapid Test Kit are various type of test kits available in the market.
On the basis of application, the target market is classified into hospitals, clinics, laboratories and others.
Regional Insights:
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
On basis of region the Global Monkeypox Disease Diagnostics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia-pacific market is estimated to witness a significantly high revenue share over the forecast period, owing to growing population, especially in countries such as India and China, and technological advancements. Moreover, rising presence of drug manufacturers is anticipated to increase demand for Global Monkeypox Disease Diagnostics Market in the region.
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2019 |
|
Forecast period |
2019 – 2030 |
|
Market representation |
Revenue in USD Million & CAGR from 2019 to 2030 |
|
Market Segmentation |
By Type – Polymerase Chain Reaction, Biopsy, Antigen Detection Method, Rapid Test Kits and Others. By Application – Hospitals, Clinics, Laboratories and Others. |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Global Monkeypox Disease Diagnostics report based on test, application, and region:
Global Monkeypox Disease Diagnostics Market, By Type:
- PCR (Polymerase Chain Reaction)
- Biopsy
- Antigen Detection Method
- Rapid Test Kits
- Others
Global Monkeypox Disease Diagnostics Market, By Application:
- Hospitals
- Clinics
- Laboratories
Global Monkeypox Disease Diagnostics Market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- North America
-
Monkeypox Disease Diagnostics Market Key Players
The key players operating the Global Monkeypox Disease Diagnostics Market includes companies like Aegis Science, Labcorp, Mayo Clinic Laboratories, Quest Diagnostics, Sonic Healthcare, Abbott Diagnostics, Applied DNA Sciences, Beckman Coulter Diagnostics, Becton-Dickinson and Company, BioGX, bioMerieux Diagnostics, Bio-Rad Laboratories Inc., Cepheid, CerTest Biotec, Creative Biogene, Flow Health, Qiagen Gmbh, Roche, Siemens Healthineers, Sysmex, and Thermo Fisher Scientific Inc.
July 2022, Aegis Sciences to Begin Monkeypox Testing Today, Increasing Nationwide Testing Capacity. Aegis Sciences will begin testing for Monkeypox using CDC’s orthopoxvirus, which detects most non-smallpox related orthopoxviruses, including Monkeypox virus. Aegis expects to be able to perform up to 10,000 tests per week, increasing the current capacity provided through CDC’s Laboratory Response Network (LRN), Labcorp, Mayo Clinic Laboratories and Quest Diagnostics to up to 70,000 tests per week by the end of the month.
Monkeypox Disease Diagnostics Market Company Profile
- Aegis Science*
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Labcorp
- Mayo Clinic Laboratories
- Quest Diagnostics
- Sonic Healthcare
- Abbott Diagnostics
- Applied DNA Sciences
- Beckman Coulter Diagnostics
- Beckton, Dickinson and Company
- BioGx
- bioMerieux Diagnostics
- Bio-Rad Laboratories Inc.,
- Cepheid
- CerTest Biotec
- Creative Biogene
- Flow Health
- Qiagen Gmbh
- Roche Molecular Diagnostics
- Siemens Healthineers
- Sysmex
- Thermo Fisher Scientific Inc.
“*” marked represents similar segmentation in other categories in the respective section
Monkeypox Disease Diagnostics Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Preview
- Executive Summary
- Key Findings—Global Outlook for medical carts Strategies
- Key Questions this Study will Answer
- Market Snippet, By Type
- Market Snippet, By Application
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restrains
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Monkeypox Disease Diagnostics Market, By Type
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- PCR (Polymerase Chain Reaction)
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Biopsy
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Antigen Detection Method
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Rapid Test Kits
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
-
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Global Monkeypox Disease Diagnostics Market, By Application, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Clinics
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Laboratories
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Monkeypox Disease Diagnostics Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Aegis Science
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Labcorp
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Mayo Clinic Laboratories
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Quest Diagnostics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Sonic Healthcare
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Abbott Diagnostics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Applied DNA Sciences
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Beckman Coulter Diagnostics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Becton, Dickinson and Company
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- BioGX
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- bioMerieux Diagnostics
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Bio-Rad Laboratories Inc.,
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Cepheid
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- CerTest Biotec
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Creative Biogene
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Flow Health
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Qiagen Gmbh
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Roche Molecular Diagnostics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Siemens Healthineers
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Sysmex
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Thermo Fisher Scientific Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Others
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The Monkeypox Disease Diagnostics Market is segmented into basis of type, application and region.
Due to technological advancements in Rapid Antigen Detection Kits, Medical Products, and Therapies that are significantly more effective and affordable clinically than their conventional equivalents, the market for monkeypox disease diagnostics is expanding globally.
By region, The Asia-pacific market is estimated to witness a significantly high revenue share over the forecast period, owing to growing population, especially in countries such as India and China, and technological advancements.
The Key players operating in the Global Monkeypox Disease Diagnostics Market include Aegis Science, Labcorp, Mayo Clinic Laboratories, Quest Diagnostics, Sonic Healthcare, Abbott Diagnostics, Applied DNA Sciences, Beckman Coulter Diagnostics, Becton-Dickinson and Company, BioGX, bioMerieux Diagnostics, Bio-Rad Laboratories Inc., Cepheid, CerTest Biotec, Creative Biogene, Flow Health, Qiagen Gmbh, Roche, Siemens Healthineers, Sysmex, and Thermo Fisher Scientific Inc.